200,000+ products from a single source!
sales@angenechem.com
Home > Other Building Blocks > 13074-60-7
13074-60-7 | 2-Butenedioic acid, 2-ethyl-, (2Z)-
CAS No: 13074-60-7 Catalog No: AG000UW5 MDL No:
Product Description
Catalog Number:
AG000UW5
Chemical Name:
2-Butenedioic acid, 2-ethyl-, (2Z)-
CAS Number:
13074-60-7
Molecular Formula:
C6H8O4
Molecular Weight:
144.1253
IUPAC Name:
2-ethylbut-2-enedioic acid
InChI:
InChI=1S/C6H8O4/c1-2-4(6(9)10)3-5(7)8/h3H,2H2,1H3,(H,7,8)(H,9,10)
InChI Key:
SASYHUDIOGGZCN-UHFFFAOYSA-N
SMILES:
CC/C(=C/C(=O)O)/C(=O)O
Properties
Complexity:
180
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
144.042g/mol
Formal Charge:
0
Heavy Atom Count:
10
Hydrogen Bond Acceptor Count:
4
Hydrogen Bond Donor Count:
2
Isotope Atom Count:
0
Molecular Weight:
144.126g/mol
Monoisotopic Mass:
144.042g/mol
Rotatable Bond Count:
3
Topological Polar Surface Area:
74.6A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
1
XLogP3:
0.4
Literature
| Title | Journal |
|---|---|
| Characterization of a thermostable methylaspartate ammonia lyase from Carboxydothermus hydrogenoformans. | Applied microbiology and biotechnology 20120401 |
| Pharmacokinetics of anti-psoriatic fumaric acid esters in psoriasis patients. | Archives of dermatological research 20100901 |
| Fumaric acid dialkyl esters deprive cultured rat oligodendroglial cells of glutathione and upregulate the expression of heme oxygenase 1. | Neuroscience letters 20100507 |
| Fumarase: a mitochondrial metabolic enzyme and a cytosolic/nuclear component of the DNA damage response. | PLoS biology 20100301 |
| Cut and paste: a novel method of re-attaching rectus muscles with cyanoacrylate during recessions in strabismus. | Indian journal of ophthalmology 20100101 |
| Fumaric Acid and its esters: an emerging treatment for multiple sclerosis. | Current neuropharmacology 20090301 |
| Fumaric acid and its derivatives in the treatment of psoriasis vulgaris: our experience in forty-one patients. | Acta dermatovenerologica Croatica : ADC 20090101 |
| Fumaric acid esters. | Clinics in dermatology 20080101 |
| Dimethylfumarate induces immunosuppression via glutathione depletion and subsequent induction of heme oxygenase 1. | The Journal of investigative dermatology 20070401 |
| Use of fumaric acid esters in psoriasis. | Indian journal of dermatology, venereology and leprology 20070101 |
| BG 12: BG 00012, BG 12/Oral Fumarate, FAG-201, second-generation fumarate derivative--Fumapharm/Biogen Idec. | Drugs in R&D 20050101 |
| Pharmacokinetics of oral fumarates in healthy subjects. | British journal of clinical pharmacology 20041001 |
| In vitro pharmacokinetics of anti-psoriatic fumaric acid esters. | BMC pharmacology 20040101 |
| Presystemic metabolism and intestinal absorption of antipsoriatic fumaric acid esters. | Biopharmaceutics & drug disposition 20030901 |
| Plausible molecular mechanism for activation by fumarate and electron transfer of the dopamine beta-mono-oxygenase reaction. | The Biochemical journal 20021001 |
| Treatment of disseminated granuloma annulare with fumaric acid esters. | BMC dermatology 20020101 |
| Successful treatment of recalcitrant cutaneous sarcoidosis with fumaric acid esters. | BMC dermatology 20020101 |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.